Title of article
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Author/Authors
Paul Emery، نويسنده , , Ferdinand C Breedveld، نويسنده , , Stephen Hall، نويسنده , , Patrick Durez، نويسنده , , David J Chang، نويسنده , , Deborah Robertson، نويسنده , , Amitabh Singh، نويسنده , , Ronald D Pedersen، نويسنده , , Andrew S Koenig، نويسنده , , Bruce Freundlich، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
375
To page
382
Abstract
Summary
Background
Remission and radiographic non-progression are goals in the treatment of early rheumatoid arthritis. The aim of the combination of methotrexate and etanercept in active early rheumatoid arthritis (COMET) trial is to compare remission an
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
593257
Link To Document